Literature DB >> 8317122

Trousseau's syndrome.

N Callander1, S I Rapaport.   

Abstract

We report 4 cases of Trousseau's syndrome, in which spontaneous recurrent or migratory venous thromboses, arterial emboli caused by nonbacterial thrombotic endocarditis, or both, develop in a patient with a recognized or occult malignant tumor. The clinical course of 3 of the patients emphasizes a key point: The occurrence for no known reason of thromboses preventable by anticoagulation therapy with heparin but not with warfarin sodium should alert a physician to focus diagnostic efforts on uncovering an underlying malignant lesion. Thromboses may occur months to years before the tumor is discovered, and a thorough negative initial examination does not obviate the need for a continuing search. Patients with Trousseau's syndrome have persistent low-grade intravascular coagulation, and therapy with heparin should be continued indefinitely. Stopping heparin therapy for even a day may permit a new thrombosis to develop. Immunostaining a biopsy specimen from 1 patient provided evidence that 2 properties of a neoplastic lesion are required for the syndrome to develop: The malignant cells express surface membrane tissue factor, and structural features of the tumor permit the malignant cells or vesicles it sheds to be exposed to circulating blood.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8317122      PMCID: PMC1022062     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  31 in total

1.  MIGRATORY VENOUS THROMBOSIS AND CANCER.

Authors:  J NUSBACHER
Journal:  N Y State J Med       Date:  1964-09-01

2.  Thrombophlebitis and cancer.

Authors:  J S LIEBERMAN; J BORRERO; E URDANETA; I S WRIGHT
Journal:  JAMA       Date:  1961-08-26       Impact factor: 56.272

3.  A morphologic study of pancreatic carcinoma with reference to multiple thrombi.

Authors:  C J LAFLER; D L HINERMAN
Journal:  Cancer       Date:  1961 Sep-Oct       Impact factor: 6.860

4.  Disseminated thrombosis in colon cancer.

Authors:  D G MCKAY; G H WAHLE
Journal:  Cancer       Date:  1955 Sep-Oct       Impact factor: 6.860

5.  Acute hemorrhagic syndrome with hypofibrinogenemia in metastatic cancer.

Authors:  P G FRICK
Journal:  Acta Haematol       Date:  1956-07       Impact factor: 2.195

6.  Venous thrombosis and obscure visceral carcinoma; report of ten cases.

Authors:  S PERLOW; J L DANIELS
Journal:  AMA Arch Intern Med       Date:  1956-02

7.  The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas.

Authors:  G F Pineo; E Regoeczi; M W Hatton; M C Brain
Journal:  J Lab Clin Med       Date:  1973-08

8.  Tumor shedding and coagulation.

Authors:  H F Dvorak; S C Quay; N S Orenstein; A M Dvorak; P Hahn; A M Bitzer; A C Carvalho
Journal:  Science       Date:  1981-05-22       Impact factor: 47.728

9.  Mucinous malignancies, venous thrombosis and terminal endocarditis with emboli. A syndrome.

Authors:  R F Rohner; J T Prior; J H Sipple
Journal:  Cancer       Date:  1966-12       Impact factor: 6.860

10.  Trousseau's syndrome. Devastating coagulopathy in the absence of heparin.

Authors:  W R Bell; N F Starksen; S Tong; J K Porterfield
Journal:  Am J Med       Date:  1985-10       Impact factor: 4.965

View more
  10 in total

1.  Trousseau's syndrome treated with long-term subcutaneous lepirudin (case report and review of the literature).

Authors:  A C Andreescu; M Cushman; J M Hammond; M E Wood
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

Review 2.  Trousseau's syndrome: multiple definitions and multiple mechanisms.

Authors:  Ajit Varki
Journal:  Blood       Date:  2007-05-11       Impact factor: 22.113

3.  Trousseau syndrome.

Authors:  Barry Ladizinski; Daniel G Federman
Journal:  CMAJ       Date:  2012-11-26       Impact factor: 8.262

4.  Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome.

Authors:  Bojing Shao; Mark G Wahrenbrock; Longbiao Yao; Tovo David; Shaun R Coughlin; Lijun Xia; Ajit Varki; Rodger P McEver
Journal:  Blood       Date:  2011-08-22       Impact factor: 22.113

Review 5.  Anticoagulant therapy in special circumstances.

Authors:  T G DeLoughery
Journal:  Curr Cardiol Rep       Date:  2000-01       Impact factor: 2.931

6.  Microvesicle-associated tissue factor and Trousseau's syndrome.

Authors:  I Del Conde; L D Bharwani; D J Dietzen; U Pendurthi; P Thiagarajan; J A López
Journal:  J Thromb Haemost       Date:  2007-01       Impact factor: 5.824

7.  Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas.

Authors:  Mark Wahrenbrock; Lubor Borsig; Dzung Le; Nissi Varki; Ajit Varki
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

Review 8.  Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer.

Authors:  Madhumita Chatterjee; Laura C Hurley; Michael A Tainsky
Journal:  Gynecol Oncol Rep       Date:  2017-06-15

9.  Thrombophlebitis Migrans (Trousseau Syndrome) in Pancreatic Adenocarcinoma: An Autopsy Report.

Authors:  George S Stoyanov; Deyan L Dzhenkov; Maria Tzaneva
Journal:  Cureus       Date:  2019-08-30

10.  An Autopsy Case of Lambl's Excrescences with Trousseau Syndrome that Caused Cardioembolic Stroke.

Authors:  Takehisa Hirayama; Harumi Morioka; Hideomi Fujiwara; Konosuke Iwamoto; Tetsuhito Kiyozuka; Hiroteru Takeo; Ken Ikeda; Osamu Kano
Journal:  Intern Med       Date:  2020-08-04       Impact factor: 1.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.